原发性低分化尿路上皮型前列腺腺癌一例的FDG PET/CT表现
FDG PET/CT in a Case With Primary Poorly Differentiated Urothelial-Type Adenocarcinoma of the Prostate.
PubMed 文献 · Clin Nucl Med · 2022-04-04
本文报道一例原发性低分化尿路上皮型前列腺腺癌伴盆腔淋巴结转移的FDG PET/CT表现。前列腺肿瘤及转移灶均显示FDG摄取增高。患者血清前列腺特异性抗原正常而癌胚抗原升高,可能有助于鉴别诊断。
要点
- 原发性尿路上皮型前列腺腺癌极为罕见,前列腺肿瘤及盆腔淋巴结转移灶均呈FDG高摄取。
- 患者血清前列腺特异性抗原正常、癌胚抗原升高,可能有助于鉴别诊断。
核心结论
- 原发性低分化尿路上皮型前列腺腺癌的前列腺肿瘤及盆腔淋巴结转移灶在FDG PET/CT上均显示FDG摄取增高。
研究设计与样本
- 本文为病例报告,描述一例原发性低分化尿路上皮型前列腺腺癌伴盆腔淋巴结转移患者的FDG PET/CT表现。
主要发现
- 前列腺肿瘤及转移性病灶均显示FDG摄取增高。
- 患者血清前列腺特异性抗原正常,癌胚抗原升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary urothelial-type adenocarcinoma of the prostate is extremely rare. We describe FDG PET/CT findings in a case with primary poorly differentiated urothelial-type adenocarcinoma of the prostate with pelvic lymph node metastases. Both the prostate tumor and its metastatic lesions showed intense FDG uptake. The patient had normal serum prostate-specific antigen and elevated carcinoembryonic antigen levels, which may be helpful for the differential diagnosis.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Dong A, Zhu Y, Zuo C, et al. FDG PET/CT in a Case With Primary Poorly Differentiated Urothelial-Type Adenocarcinoma of the Prostate. Clin Nucl Med. 2022. PMID: 35797631. doi:10.1097/RLU.0000000000004150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。